Scotland says ‘Yes’ to Hyftor for facial angiofibromas!
Decision-makers in Scotland have agreed to fund Hyftor (topical sirolimus) through NHS Scotland to treat facial angiofibromas (marks and bumps on the face caused by TSC) The TSA is delighted that the Scottish Medicines Consortium (SMC) has recognised that Hyftor (topical sirolimus) is an